N00.B1
Acute nephritic syndrome with idiopathic immune membranoproliferative glomerulonephritis (IC-MPGN)
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute nephritic syndrome with idiopathic immune membranoproliferative glomerulonephritis (IC-MPGN) is a kidney disorder characterized by inflammation of the glomeruli, which are tiny filters in the kidneys. This condition results in impaired kidney function, leading to symptoms like blood in the urine, swelling, and reduced urine output. It is considered a serious condition requiring prompt medical attention to prevent long-term kidney damage.
Causes & Symptoms
Clinical Causes: Immune system malfunctions where the body's immune response mistakenly targets the kidneys, causing inflammation. Unknown exact cause leading to autoimmune reactions; hence the term 'idiopathic'. Possible genetic predisposition influencing immune responses. Chronic infections or other systemic diseases that may contribute to immune complex deposition in the glomeruli. Environmental factors that could trigger immune responses affecting the kidneys.
Key Symptoms: Hematuria: presence of blood in the urine, causing it to appear pink or cola-colored. Proteinuria: excess protein in the urine, often leading to foaminess. Edema: swelling in the face, hands, feet, or abdomen due to fluid retention. Hypertension: increased blood pressure resulting from disrupted kidney function. Oliguria: decreased urine output. General malaise and fatigue due to reduced kidney efficiency. Possible fever and flank pain in some cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory testing. Urinalysis will typically show blood and protein. Blood tests may reveal impaired kidney function and signs of inflammation. Sometimes, a kidney biopsy is performed to confirm the diagnosis by examining tissue samples for characteristic changes associated with IC-MPGN. Imaging studies such as ultrasound may be used to assess kidney size and structure.
Treatment Protocols: Treatment strategies aim to control symptoms and suppress the immune response to prevent further kidney damage. Common approaches include: - Immunosuppressive therapies: corticosteroids or other medications that reduce immune system activity. - Blood pressure management: antihypertensive drugs to lower blood pressure and decrease kidney stress. - Diuretics: medications to manage edema by promoting fluid elimination. - Dietary modifications: reducing salt intake to help control blood pressure and swelling. - Monitoring kidney function regularly to assess disease progression. - In some cases, plasmapheresis or other advanced therapies may be considered. The specific treatment plan depends on the severity of the condition and the patient’s overall health, and it requires close coordination with healthcare professionals.
Clinical Advice & FAQs
Billing Guidance
Is N00.B1 a billable ICD-10 code?
Yes, N00.B1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N00.B1?
Clinical documentation must specify the nature of Acute nephritic syndrome with idiopathic immune membranoproliferative glomerulonephritis (IC-MPGN) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
